UGC Approved Journal no 63975

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 10 | Issue 2 | February 2023

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 3 Issue 6
June-2016
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1701161


Registration ID:
225088

Page Number

777-792

Share This Article


Jetir RMS

Title

Optimization, Characterization of Artemether and Lumefantrine Nanosuspension for Solubility and Bioavailability Enhancement

Abstract

Present study describes the formulation of Nano suspension System of Antimalarial Drugs Artemether and Lumefantrine with lipids and surfactants which enchanced the solubility and bioavailability. The poorly soluble drugs, were considered to be fit for nanosuspension to improve its solubility. The study intended to preparation of nano suspension by means ofZirconium beads milling method and furtherLyophillisation. Artemether Lumefantrine consists of PVP and SLS. Nanopowders were further characterized for particle size, Zeta Potential and Drug contentwas to be 732.9 nm, -0.2 mV and 99.25 %. During the screening processes, the formulation showed a smaller particle size and stability during lyophilization.In vitrostudies reported to be90.34±0.21% for Artemether and 92.03±0.72%for Lumefantrine. The in vitropercent drug release of Artemether and Lumefantrine from Nanopowder found to be higher as compared to marketed formulation (Lumerax®) and pure drugs. The Drug Excipient compatibility studies carried by FT-IR and XRD depicted that there was no interaction between drugs and excipients.Moreover it was suggested that stabilizersPVP and SLS were appreciated excipients on the Nanopowder platform and exhibited the abilities of size-reduction and stability-maintaining on freeze-drying

Key Words

Anti-malarials, Nanosuspension, Freeze drying, enhanced solubility, dissolution, Oral bioavailability

Cite This Article

"Optimization, Characterization of Artemether and Lumefantrine Nanosuspension for Solubility and Bioavailability Enhancement", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.3, Issue 6, page no.777-792, June-2016, Available :http://www.jetir.org/papers/JETIR1701161.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Optimization, Characterization of Artemether and Lumefantrine Nanosuspension for Solubility and Bioavailability Enhancement", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.3, Issue 6, page no. pp777-792, June-2016, Available at : http://www.jetir.org/papers/JETIR1701161.pdf

Publication Details

Published Paper ID: JETIR1701161
Registration ID: 225088
Published In: Volume 3 | Issue 6 | Year June-2016
DOI (Digital Object Identifier):
Page No: 777-792
Country: -, -, - .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003062

Print This Page

Current Call For Paper

Jetir RMS